Snowball logo
logo
IPDQ_logo

ImpediMed Limited

IPDQF • PINK
$0.0039$0.00  (0%)
Estimate
EPS
-0.01
Beta
1.068
Growth
Revenue, YoY
28.04%
Net income, YoY
-25.17%
About the company
Ticker
IPDQF
ISIN
Country
Australia
Sector (GICS)
Healthcare
ImpediMed Limited, a medical technology company, engages in the development, manufacture, and sale of bioimpedance spectroscopy (BIS) systems and software services in Australia, Europe, North America, and internationally. The company offers SOZO Digital Health Platform which transforms fluid status and tissue composition into insights with a single scan; L-Dex Analysis for Lymphedema, designed for early lymphedema detection; BodyComp Analysis; Segmental BodyComp Analysis; and HF-Dex Analysis for Heart Failure. It also provides Lymphedema Prevention Program; and BodyComp Analysis for survivorship health. The company specializes in cancer survivorship, heart health management, medical weight management, wellness, and research. ImpediMed Limited was incorporated in 1999 and is headquartered in Carlsbad, California.

Frequently asked questions

What sector does ImpediMed Limited (IPDQF) operate in?

ImpediMed Limited belongs to the Healthcare sector and operates in the Medical Devices industry.

What is ImpediMed Limited (IPDQF) current stock price?

As of the latest data, ImpediMed Limited stock price is $0.00, with a previous close of $0.00.

What is ImpediMed Limited (IPDQF) current market capitalization?

ImpediMed Limited market cap is approximately 14.28 million.

What is ImpediMed Limited (IPDQF) Earnings Per Share (EPS)?

The trailing EPS is -$0.01.

What is ImpediMed Limited (IPDQF) EBITDA?

ImpediMed Limited EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -7.50 million.

Does ImpediMed Limited (IPDQF) pay dividends?

No. ImpediMed Limited does not pay a dividend.

What is ImpediMed Limited (IPDQF) beta (volatility) score?

ImpediMed Limited has a beta of 1.068, meaning its volatility is roughly in line with the market.